Quick Answer
COSCIENS Biopharma Inc. reported Total Assets of $21.43 million for fiscal year 2025.
COSCIENS Biopharma Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $21.43M | -38.9% |
| 2024 | $35.07M | +47.7% |
| 2023 | $23.75M | -37.1% |
| 2022 | $37.73M | -52.9% |
| 2021 | $80.10M | +116.5% |
| 2020 | $37.01M | +85.2% |
| 2019 | $19.98M | -20.1% |
| 2018 | $25.01M | +12.7% |
| 2017 | $22.20M | -29.9% |
| 2016 | $31.66M | — |
- COSCIENS Biopharma Inc. showed a decrease of -38.9% in Total Assets compared to the prior fiscal year.
- Over the 2016–2025 period, COSCIENS Biopharma Inc.’s total assets has declined by 32.3% (from $31.66 million to $21.43 million).
- The most recent figure is from COSCIENS Biopharma Inc.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: